CBUS (CBUS) Stock Price & Analysis
CBUS (CBUS) rose 1.26% to USD 1.61 as of September 9, 2026 at 12:05 UTC, according to Nexqual real-time market data.
CBUS last closed at USD 1.61; the session ranged USD 1.6–1.64 on volume of 70,891 shares. Market capitalization is —, with a 52-week range of USD 1.09–4.19 (NCM). Source: Nexqual, September 9, 2026 at 12:05 UTC.
Key Statistics (as of September 9, 2026 at 12:05 UTC)
| Price | USD 1.61 |
|---|---|
| Change | ▲ 1.26% (up) |
| Previous Close | USD 1.61 |
| Open | USD 1.61 |
| Day Range | USD 1.6 – 1.64 |
| 52-Week Range | USD 1.09 – 4.19 |
| Volume | 70,891 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CBUS)
Nexqual's technical model rates CBUS "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 12:05 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.87 (neutral) |
| vs SMA50 | Below (USD 1.76) |
| MACD | -0.05 (negative) |
From CBUS's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | USD 5.43 | ▲ 14.56% |
| ACRV | Acrivon Therapeutics, Inc. | USD 2.1 | ▲ 1.94% |
| GNLX | Genelux Corporation | USD 2.54 | ▲ 0.79% |
| COYA | Coya Therapeutics, Inc. | USD 4.61 | ▲ 1.32% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 4.03 | ▼ 1.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:05 UTC. This page is informational and not investment advice.